Polaris divests Hamlet Protein
Polaris invested in Hamlet Protein in 2007 and has succesfully developed the company into a global leading provider of advanced soy-based specialty feed ingredients.
Today, Polaris signed a deal regarding the sale of Polaris II shares in Hamlet Protein A/S to a consortium consisting of Goldman Sachs Merchant Banking and Altor Equity Partners.
Please find the press releases below
For more information please contact
Niels Worning, Partner
Phone: +45 35 25 34 57